MARTIN TAMI TILLOTSON (Sr. V.P., Regulatory Affairs) sold 8.5% of their position (8K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $223.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/12/2024ACC: 0001104659-24-003741
Officer· Sr. V.P., Regulatory Affairs
Since Feb 2020
-8K
Net shares
Net seller
$223.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8K acquired · 16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
$9.24
Trade value
$73.92K
% of position
9.3%
1/10/2024
85.66K→93.66K
Common Stock
Direct
Shares
−8K
Price / share
$27.91
Trade value
$223.28K
% of position
8.5%
1/10/2024
93.66K→85.66K
Total
Net shares
+0.00
Net value
-$149.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2024 | M · Option Exercise | +8K | $9.24 | $73.92K | 9.3% | 85.66K | 93.66K |
| Common Stock Direct | 1/10/2024 | S · Sale | −8K | $27.91 | $223.28K | 8.5% | 93.66K | 85.66K |
| Total | +0.00 | -$149.36K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8K shares
Shares
−8K
Strike price
9.24
Held after
0.00
Exercisable
—
1/10/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock8K shares | 1/10/2024 | M · Option Exercise | −8K | 9.24 | — | 0.00 |